
    
      The trial is a clinical, single-center, randomized trial study that will involve 30 adult
      cancer patients with chemotherapy-induced peripheral neuropathy randomized into two groups
      (control and acupuncture treated with 10 sessions, 2X per week). Both CIPN patients groups
      will be submitted to a complete physical examination and to clinical assessments with
      National Cancer Institute Common Terminology Criteria for Adverse Events Scale Version 2.0,
      Functional Independence Measure Scale, European Organisation for the Research and Treatment
      of Cancer Quality of Life Questionnaire Core 30 Scale and Visual Analogue Scale for pain
      before treatment and in 5 weeks of follow-up after treatment.
    
  